| Choosing to participate
in a clinical trial is an important personal decision. This
decision impacts not only an individual’s personal
treatment plan, but has larger implications for the scientific,
medical, and community-at-large. This half-hour program
focuses on this important form of medical research and considers
the risks and benefits of participation, bioethical concerns
regarding informed consent, minority recruitment, and myths
and misconceptions associated with clinical trials. A panel
of research physicians involved in spinal cord injury and
Alzheimer’s Disease, along with a bioethicist from
the National Institute of Health, and an individual who
has participated in a clinical trail for cancer treatment
discusses how this type of research study in humans answers
specific health questions.
www.ClinicalTrials.gov
Dr. Christine Grady
|
Dr. Robert Heary |
Dr. Karen Bell
|
Joanne Scesa |
|
| Guests:
- Dr. Christine Grady, A bioethicist
working on Human Subjects Research at the National Institutes
of Health, in Bethesda, Maryland.
- Dr. Robert Heary, Director of The Spine
Center for New Jersey Medical School at
the University of Medicine and Dentistry of New Jersey,
in Newark New Jersey.
- Dr. Karen Bell, Director of Alzheimer’s
Clinical Trials and Associate Clinical Professor of neurology
at Columbia University.
- Joanne Scesa, A cancer survivor who
participated in a clinical trial as part of treatment
for Melanoma.
|
